| Identification | Back Directory | [Name]
Phenol, 3-[(6,7-diMethoxy-4-quinazolinyl)aMino]- | [CAS]
211555-08-7 | [Synonyms]
Janex 3
WHI-P180, >98%
WHI-P180(Janex 3)
WHI P180;JANEX3;WHIP180;JANEX-3
3-(6,7-dimethoxyquinazolin-4-ylamino)phenol
3-[(6,7-Dimethoxy-4-quinazolinyl)amino]phenol
Phenol, 3-[(6,7-diMethoxy-4-quinazolinyl)aMino]-
3-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol (Related Reference) | [Molecular Formula]
C16H15N3O3 | [MDL Number]
MFCD02683970 | [MOL File]
211555-08-7.mol | [Molecular Weight]
297.31 |
| Chemical Properties | Back Directory | [Boiling point ]
476.5±40.0 °C(Predicted) | [density ]
1.336±0.06 g/cm3(Predicted) | [storage temp. ]
Keep in dark place,Sealed in dry,2-8°C | [solubility ]
DMSO : 25 mg/mL (84.09 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble) | [form ]
Powder | [pka]
9.58±0.10(Predicted) |
| Hazard Information | Back Directory | [Biological Activity]
WHI-P180 is an inhibitor of multiple kinases with IC50 values of 4.5 nM and 66 nM for RET (c-RET) and KDR, respectively. | [in vivo]
WHI-P180 is also an active inhibitor of IgE-mediated mast cell responses. The elimination half-life of WHI-P180 in CD-1 mice (BALB/c mice) following iv, ip, or po administration is less than 10 min. Systemic clearance of WHI-P180 is 6742 mL/h/kg in CD-I mice and 8188 mL/h/kg in BALB/c mice. Notably, WHI-P180, when administered in two consecutive nontoxic ip bolus doses of 25 mg/kg, inhibits IgE/antigen-induced vascular hyperpermeability in a well-characterized murine model of passive cutaneous anaphylaxis. | [target]
| Target | Value | RET
(Cell-free assay) | 4.5 nM | KDR
(Cell-free assay) | 66 nM |
| [storage]
Store at -20°C |
|
|